Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults.
| Condition(s) | Cardiovascular Diseases |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults. |
| Who can participate | Inclusion Criteria: * Residents in the Yinzhou District have a unique health ID; * Aged 40 to 79 years at the baseline enrollment; * With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year riskā„10%); Exclusion Criteria: * Have a history of coronary heart disease, stroke or heart failure; * Patients with a diagnosis of cancer; * Refused to provide written informed consent |
| Ages | 40 Years to 79 Years |
| Sex | All |
| Lead sponsor | Peking University |
| Locations | Ningbo, Zhejiang, China |
| Start date | 2023-07-06 |
| NCT ID | NCT05919056 |
| Official listing | https://clinicaltrials.gov/study/NCT05919056 |